|
Medicinal plant
|
Con (μl/ml)
|
μl/disc
|
Gram positive
|
Gram negative
|
|---|
|
MSSA
|
MRSA
|
E. coli
|
K. pneumoniae
|
|---|
|
R
|
S
|
R
|
S
|
|---|
|
T.schimper
|
100
|
10
|
16 ± 0.9
|
16 ± 0.4
|
11 ± 0.4
|
10 ± 0.7
|
17 ± 0.4
|
17 ± 1.2
|
|
100
|
20
|
21 ± 0.6*
|
21 ± 0.3
|
17 ± 0.4
|
13 ± 0.1
|
24 ± 0.2#
|
24 ± 1.0
|
|
B. cuspidata
|
100
|
10
|
19 ± 0.3
|
19 ± 0.2
|
15 ± 1.3
|
11 ± 0.3
|
19 ± 0.3
|
18 ± 0.2
|
|
100
|
20
|
22 ± 0.6*
|
25 ± 0.1
|
19 ± 0.8
|
15 ± 0.1
|
23 ± 0.3#
|
23 ± 0.9
|
|
B. ogadensis
|
100
|
10
|
13 ± 0.8
|
12 ± 0.1
|
9 ± 0.2
|
8 ± 0.7
|
17 ± 0.9
|
17 ± 0.3
|
|
100
|
20
|
19 ± 0.8
|
17 ± 0.3
|
14 ± 0.2
|
14 ± 0.2
|
20 ± 0.6
|
21 ± 0.9
|
|
Positive control
|
Cefoxitin
|
S
|
R
|
–
|
–
|
–
|
–
|
|
Gentamicin
|
–
|
–
|
R
|
S
|
R
|
S
|
|
Ceftriaxone
|
–
|
–
|
R
|
S
|
R
|
S
|
|
Negative control (5% DMSO)
|
N
|
N
|
N
|
N
|
N
|
N
|
- The values represent mean ± standard deviation, N NO inhibition zone, R Resistant (≤16 mm IZ), S Susceptible (≥ 21 mm IZ). Where, *P < 0.05when compared to cefoxitin treated MRSA. While, #P < 0.05 when compared to modern drug treated K. pneumoniae
